Eli Lilly and Co
LLY
UnitedHealth
UNH
Tractor Supply
TSCO
4
Humana
HUM
5
Builders FirstSource
BLDR
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -31.69%1.27B | -51.64%221M | 37.19%498M | -39.53%231M | -51.13%324M | 9.00%1.87B | -20.66%457M | -7.87%363M | -12.79%382M | 118.81%663M |
Net income from continuing operations | -101.46%-9M | -28.79%188M | -262.50%-39M | -158.28%-88M | -139.55%-70M | 346.38%616M | 340.00%264M | 131.17%24M | 23.77%151M | 436.36%177M |
Operating gains losses | -31.12%-889M | -129.28%-509M | -38.19%-199M | 38.22%-97M | 48.47%-84M | -518.52%-678M | ---222M | -238.46%-144M | -681.48%-157M | -625.81%-163M |
Depreciation and amortization | 8.53%2.01B | -7.74%477M | 14.73%514M | 12.88%517M | 17.02%502M | 16.99%1.85B | 26.72%517M | 16.36%448M | 17.74%458M | 6.98%429M |
Deferred tax | 82.39%-31M | 67.55%-49M | 141.67%29M | 116.67%3M | 26.32%-14M | -17.33%-176M | -32.46%-151M | 129.27%12M | -158.06%-18M | 26.92%-19M |
Other non cash items | 238.65%391M | 197.44%228M | 212.90%70M | 346.67%37M | 51.35%56M | -376.47%-282M | -788.24%-234M | -210.71%-62M | -225.00%-15M | --37M |
Change In working capital | -141.68%-198M | -144.02%-114M | 65.28%119M | -279.49%-148M | -136.61%-67M | 323.00%475M | 73.83%259M | 256.52%72M | 75.78%-39M | 218.06%183M |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | 282.43%540M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | -155.05%-60M | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | 65.28%119M | -279.49%-148M | -136.61%-67M | 80.77%-5M | -165.77%-221M | 256.52%72M | -95.00%-39M | 490.32%183M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -31.69%1.27B | -51.64%221M | 37.19%498M | -39.53%231M | -51.13%324M | 9.00%1.87B | -20.66%457M | -7.87%363M | -12.79%382M | 118.81%663M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -56.11%-6.8B | -65.76%-4.06B | -90.57%-1.01B | -347.00%-894M | 29.00%-835M | 14.02%-4.36B | -14.33%-2.45B | 55.24%-530M | 62.69%-200M | 2.24%-1.18B |
Net PPE purchase and sale | -32.89%-3.73B | -0.52%-1.16B | -51.99%-918M | -69.42%-820M | -46.85%-840M | -28.26%-2.81B | -61.38%-1.15B | -4.68%-604M | -7.80%-484M | -26.55%-572M |
Net business purchase and sale | -100.07%-3.03B | -135.20%-2.94B | -127.27%-125M | -100.00%-74M | 94.83%-9M | 43.60%-1.52B | -7.20%-1.25B | 91.78%-55M | 30.19%-37M | 78.25%-174M |
Net investment purchase and sale | ---- | ---- | 933.33%25M | -158.66%-166M | --0 | 49.53%-213M | 86.29%-44M | -250.00%-3M | 274.69%283M | -861.02%-449M |
Net other investing changes | -118.68%-34M | 585.71%34M | -93.94%8M | 336.84%166M | -26.32%14M | -22.22%182M | -112.50%-7M | 120.00%132M | -70.31%38M | 290.00%19M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -56.11%-6.8B | -65.76%-4.06B | -90.57%-1.01B | -347.00%-894M | 29.00%-835M | 14.02%-4.36B | -14.33%-2.45B | 55.24%-530M | 62.69%-200M | 2.24%-1.18B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 194.65%7.65B | 176.88%5.75B | 5,620.00%572M | 490.77%508M | 28.28%821M | -25.59%2.6B | 46.20%2.08B | -98.88%10M | -148.69%-130M | -29.67%640M |
Net issuance payments of debt | 375.88%7.71B | 126.91%4.93B | 282.08%661M | 238.08%1.18B | -250.00%-195M | -60.70%1.62B | 378.85%2.17B | -92.28%173M | -179.19%-856M | -89.80%130M |
Net common stock issuance | -106.30%-37M | --0 | --0 | -124.60%-155M | --118M | 528.47%587M | ---31M | ---12M | 815.91%630M | --0 |
Cash dividends paid | -7.17%-1.06B | -4.78%-263M | -6.80%-267M | -10.16%-271M | -7.00%-260M | -8.20%-990M | -9.61%-251M | -9.65%-250M | -7.89%-246M | -5.65%-243M |
Net other financing activities | -25.04%1.03B | 485.87%1.08B | 79.80%178M | -172.51%-248M | 53.78%1.16B | 231.25%1.38B | -84.60%184M | 108.82%99M | 168.67%342M | 985.88%753M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 194.65%7.65B | 176.88%5.75B | 5,620.00%572M | 490.77%508M | 28.28%821M | -25.59%2.6B | 46.20%2.08B | -98.88%10M | -148.69%-130M | -29.67%640M |
Net cash flow | ||||||||||
Beginning cash position | 14.33%1.14B | 22.44%1.27B | 2.83%1.24B | 24.82%1.42B | 14.33%1.14B | 10.89%998M | -8.58%1.03B | 13.50%1.2B | 25.27%1.14B | 10.89%998M |
Current changes in cash | 1,921.90%2.12B | 2,198.80%1.91B | 138.22%60M | -398.08%-155M | 144.09%310M | -21.64%105M | 156.46%83M | -253.92%-157M | -69.23%52M | 1,170.00%127M |
Effect of exchange rate changes | -350.00%-95M | -379.17%-67M | 200.00%16M | -268.75%-27M | -221.43%-17M | 235.71%38M | 9.09%24M | 46.67%-16M | 184.21%16M | 1,500.00%14M |
End cash Position | 174.76%3.14B | 174.76%3.14B | 22.44%1.27B | 2.83%1.24B | 24.82%1.42B | 14.33%1.14B | 14.33%1.14B | -8.58%1.03B | 13.50%1.2B | 25.27%1.14B |
Free cash flow | -160.49%-2.46B | -34.97%-934M | -74.27%-420M | -477.45%-589M | -667.03%-516M | -97.08%-944M | -408.82%-692M | -31.69%-241M | -827.27%-102M | 161.07%91M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |